Np mrd loader

Record Information
Version2.0
Created at2024-09-11 12:12:33 UTC
Updated at2024-09-11 12:12:33 UTC
NP-MRD IDNP0337747
Secondary Accession NumbersNone
Natural Product Identification
Common NamePhaseoloside E
Description It was first documented in 2024 (PMID: 39300590). Based on a literature review a significant number of articles have been published on Phaseoloside E (PMID: 39300589) (PMID: 39300555) (PMID: 39300536) (PMID: 39300517).
Structure
Thumb
SynonymsNot Available
Chemical FormulaC77H124O41
Average Mass1705.7980 Da
Monoisotopic Mass1704.76180 Da
IUPAC Name4-[(3-{[5-({3-[(5-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]-4,5-dihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl}oxy)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl)oxy]-3,5-dihydroxy-6-{[4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,8a,9,10,11,12,12a,12b,14a,14b-octadecahydropicen-3-yl]oxy}oxane-2-carboxylic acid
Traditional Name4-[(3-{[5-({3-[(5-{[3,4-dihydroxy-6-(hydroxymethyl)-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]-4,5-dihydroxy-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxan-2-yl}oxy)-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl)oxy]-3,5-dihydroxy-6-{[4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,9,10,12,12a,12b,14a-dodecahydropicen-3-yl]oxy}oxane-2-carboxylic acid
CAS Registry NumberNot Available
SMILES
CC1OC(OCC2OC(OC3C(O)C(O)C(OC4C(O)C(O)COC4OC4C(O)C(OC5CCC6(C)C(CCC7(C)C6C=CC6C8CC(C)(C)CCC8(C)C=CC76C)C5(C)CO)OC(C4O)C(O)=O)OC3CO)C(OC3OC(CO)C(OC4OC(CO)C(OC5OC(CO)C(O)C(O)C5O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C(O)C1O
InChI Identifier
InChI=1/C77H124O41/c1-27-39(84)43(88)49(94)64(105-27)104-25-35-42(87)45(90)62(118-68-52(97)47(92)57(33(22-80)108-68)113-66-51(96)46(91)56(32(21-79)107-66)112-65-50(95)44(89)41(86)31(20-78)106-65)71(110-35)114-58-34(23-81)109-67(53(98)48(58)93)117-61-40(85)30(83)24-103-70(61)115-59-54(99)60(63(101)102)116-69(55(59)100)111-38-12-13-74(5)36(75(38,6)26-82)11-14-77(8)37(74)10-9-28-29-19-72(2,3)15-16-73(29,4)17-18-76(28,77)7/h9-10,17-18,27-62,64-71,78-100H,11-16,19-26H2,1-8H3,(H,101,102)
InChI KeyPZPHULADDDWLGC-UHFFFAOYNA-N
Experimental Spectra
Not Available
Predicted Spectra
Not Available
Chemical Shift Submissions
Not Available
Species
Species of OriginNot Available
Chemical Taxonomy
ClassificationNot classified
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP-6.4ChemAxon
pKa (Strongest Acidic)3.35ChemAxon
pKa (Strongest Basic)-3.9ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count41ChemAxon
Hydrogen Donor Count24ChemAxon
Polar Surface Area650.27 ŲChemAxon
Rotatable Bond Count23ChemAxon
Refractivity386.73 m³·mol⁻¹ChemAxon
Polarizability171.91 ųChemAxon
Number of Rings13ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Cuccato M, Divari S, Giannuzzi D, Grange C, Moretti R, Rinaldi A, Leroux C, Sacchi P, Cannizzo FT: Extracellular vesicle miRNome during subclinical mastitis in dairy cows. Vet Res. 2024 Sep 19;55(1):112. doi: 10.1186/s13567-024-01367-x. [PubMed:39300590 ]
  2. Love S, Kannis-Dymand L, Armstrong K: Development and validation of a Disorganised Thoughts Scale: a new measure to assess thinking difficulties in the general population. BMC Psychol. 2024 Sep 19;12(1):492. doi: 10.1186/s40359-024-01988-z. [PubMed:39300589 ]
  3. Juckett LA, Banhos M, Howard ML, Walters T, Horn LM, Kinney AR, Wengerd LR: Bundling implementation strategies supports outcome measure adoption in stroke rehabilitation: preliminary findings. Implement Sci Commun. 2024 Sep 19;5(1):102. doi: 10.1186/s43058-024-00643-3. [PubMed:39300555 ]
  4. Offer S, Di Bucchianico S, Czech H, Pardo M, Pantzke J, Bisig C, Schneider E, Bauer S, Zimmermann EJ, Oeder S, Hartner E, Groger T, Alsaleh R, Kersch C, Ziehm T, Hohaus T, Ruger CP, Schmitz-Spanke S, Schnelle-Kreis J, Sklorz M, Kiendler-Scharr A, Rudich Y, Zimmermann R: The chemical composition of secondary organic aerosols regulates transcriptomic and metabolomic signaling in an epithelial-endothelial in vitro coculture. Part Fibre Toxicol. 2024 Sep 19;21(1):38. doi: 10.1186/s12989-024-00600-x. [PubMed:39300536 ]
  5. Habibagahi K, Ferrari M: Advocacy through storytelling: challenging eating disorders and eating disorders stigma. J Eat Disord. 2024 Sep 19;12(1):145. doi: 10.1186/s40337-024-01099-5. [PubMed:39300517 ]